CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 503 enrolled
Drug / intervention
YVOIRE Classic sdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02334358
NCT02334358N/ACompleted

A Multi-center, Prospective and Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Classic s Injected Into the Nasolabial Folds

LG Life Sciences·observational·Posted Jan 8, 2015·Updated Mar 13, 2019

In Brief

An observational study evaluating YVOIRE Classic s for Correction of Nasolabial Folds. Completed, enrolled 503 participants across 1 site.

Detailed Summary

To evaluate long-term safety of YVOIRE classic s by incidence of adverse events including injection site local reactions and biodegradability

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJan 8, 2015
Enrollment StartSep 1, 2014
Primary CompletionApr 1, 2016
Study CompletionAug 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 11.5 years ago

Interventions

YVOIRE Classic sdevice